{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:36:57Z","timestamp":1781271417606,"version":"3.54.1"},"reference-count":44,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2011.0475","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:20:20Z","timestamp":1525238420000},"source":"Crossref","is-referenced-by-count":25,"title":["Epidemic Keratoconjunctivitis"],"prefix":"10.3238","author":[{"given":"Birthe","family":"Meyer-R\u00fcsenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Loderst\u00e4dt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisbert","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul-Michael","family":"Kaulfers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Gesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2011,7,8]]},"reference":[{"key":"10.3238\/arztebl.2011.0475_ref1","doi-asserted-by":"crossref","unstructured":"Ford E, Nelson KE, Warren D: Epidemiology of epidemic keratoconjunctivitis. Epidemiol Rev 1987; 9: 244\u201361.","DOI":"10.1093\/oxfordjournals.epirev.a036304"},{"key":"10.3238\/arztebl.2011.0475_ref2","unstructured":"Adloch C, et al.: Auswertung der bundesweit \u00fcbermittelten Meldedaten zu Adenoviruskonjunktivitiden. Epidemiologisches Bulletin 37\/2010."},{"key":"10.3238\/arztebl.2011.0475_ref3","doi-asserted-by":"crossref","unstructured":"Sundmacher R, Hillenkamp J, Reinhard T: Prospects for therapy and prevention of adenovirus keratoconjunctivitis. Ophthalmologe 2001; 98: 991\u20131007.","DOI":"10.1007\/s003470170052"},{"key":"10.3238\/arztebl.2011.0475_ref4","doi-asserted-by":"crossref","unstructured":"Bohringer D, Birnbaum F, Reinhard T: Cyclosporin A eyedrops for keratitis nummularis after adenovirus keratoconjunctivitis. Ophthalmologe 2008; 105: 592\u20134 .","DOI":"10.1007\/s00347-008-1731-1"},{"key":"10.3238\/arztebl.2011.0475_ref5","doi-asserted-by":"crossref","unstructured":"Schrauder A, Altmann D, Laude G, et al.: Epidemic conjunctivitis in Germany, 2004. Euro Surveill 2006; 11: 185\u20137 .","DOI":"10.2807\/esm.11.07.00637-en"},{"key":"10.3238\/arztebl.2011.0475_ref6","unstructured":"Singh K: Epidemic kerato-conjunctivitis in Malaya. Med J Malaya 162; 17: 4\u201311."},{"key":"10.3238\/arztebl.2011.0475_ref7","doi-asserted-by":"crossref","unstructured":"Sambursky RP, Fram N, Cohen EJ: The prevalence of adenoviral conjunctivitis at the Wills Eye Hospital Emergency Room. Optometry 2007; 78: 236\u20139.","DOI":"10.1016\/j.optm.2006.11.012"},{"key":"10.3238\/arztebl.2011.0475_ref8","unstructured":"Tullo AB: Clinical and epidemiological features of adenovirus keratoconjunctivitis. Trans Ophthalmol Soc UK 1980; 100: 263\u20137."},{"key":"10.3238\/arztebl.2011.0475_ref9","doi-asserted-by":"crossref","unstructured":"Doerr HW: Medizinische Virologie: Grundlagen, Diagnostik, Pr\u00e4vention und Therapie viraler Erkrankungen. 2nd edition. Stuttgart: Thieme 2010; 639ff.","DOI":"10.1055\/b-001-2163"},{"key":"10.3238\/arztebl.2011.0475_ref10","doi-asserted-by":"crossref","unstructured":"Chaberny IE, Schnitzler P, Geiss HK, Wendt C: An outbreak of epidemic keratoconjunctivtis in a pediatric unit due to adenovirus type 8. Infect Control Hosp Epidemiol 2003; 24: 514\u20139 .","DOI":"10.1086\/502247"},{"key":"10.3238\/arztebl.2011.0475_ref11","unstructured":"Frickmann H: Wenn Zeitersparnis zum Risiko wird. Nosokomialer Ausbruch von Keratoconjunctivitis epidemica. Management & Krankenhaus 2010; 3: 18."},{"key":"10.3238\/arztebl.2011.0475_ref12","doi-asserted-by":"crossref","unstructured":"Robert Koch-Institut: Keratoconjunctivitis epidemica: Erkennung und Verh\u00fctung. Bundesgesundheitsblatt 1999; 42: 284\u20136.","DOI":"10.1007\/978-3-662-38283-7_49"},{"key":"10.3238\/arztebl.2011.0475_ref13","unstructured":"Robert Koch-Institut: Merkbl\u00e4tter f\u00fcr \u00c4rzte: Keratokonjunktivitis epidemica und andere Konjunktivitiden durch Adenoviren. 2010; ."},{"key":"10.3238\/arztebl.2011.0475_ref14","doi-asserted-by":"crossref","unstructured":"Reinhard T, Godehardt E, Pfahl HG, Sundmacher R: Local cyclosporin A in nummuli after keratoconjunctivitis epidemica. A pilot study. Ophthalmologe 2000; 97: 764\u20138.","DOI":"10.1007\/s003470070025"},{"key":"10.3238\/arztebl.2011.0475_ref15","doi-asserted-by":"crossref","unstructured":"Siamak NM, Kowalski RP, Thompson PP, Romanowski EG, Shanks RM, Gordon YJ: RPS Adeno Detector. Ophthalmology 2009; 116: 591.","DOI":"10.1016\/j.ophtha.2008.10.025"},{"key":"10.3238\/arztebl.2011.0475_ref16","doi-asserted-by":"crossref","unstructured":"Trauzettel-Klosinski S, Sundmacher R, Wigand R: The effects of topical steroids in epidemic kerato-conjunctivitis. Klin Monbl Augenheilkd 1980; 176: 899\u2013906.","DOI":"10.1055\/s-2008-1057579"},{"key":"10.3238\/arztebl.2011.0475_ref17","doi-asserted-by":"crossref","unstructured":"Romanowski EG, Roba LA, Wiley L, Araullo-Cruz T, Gordon YJ: The effects of corticosteroids of adenoviral replication. Arch Ophthalmol 1996; 114: 581\u20135.","DOI":"10.1001\/archopht.1996.01100130573014"},{"key":"10.3238\/arztebl.2011.0475_ref18","doi-asserted-by":"crossref","unstructured":"Ward JB, Siojo LG, Waller SG: A prospective, masked clinical trial of trifluridine, dexamethasone, and artificial tears in the treatment of epidemic keratoconjunctivitis. Cornea 1993; 12: 216\u201321.","DOI":"10.1097\/00003226-199305000-00006"},{"key":"10.3238\/arztebl.2011.0475_ref19","doi-asserted-by":"crossref","unstructured":"Little JM, Lorenzetti DW, Brown DC, Schweem HH, Jones BR, Kaufman HE: Studies of adenovirus type 3 infection treated with methisazone and trifluorothymidine. Proc Soc Exp Biol Med 1968; 127: 1028\u201332.","DOI":"10.3181\/00379727-127-32862"},{"key":"10.3238\/arztebl.2011.0475_ref20","doi-asserted-by":"crossref","unstructured":"Hutter H: Epidemic keratoconjunctivitis: treatment results during an epidemic. Klin Monbl Augenheilkd 1990; 197: 214\u20137.","DOI":"10.1055\/s-2008-1046272"},{"key":"10.3238\/arztebl.2011.0475_ref21","doi-asserted-by":"crossref","unstructured":"Waring G: Use of vidarabine in epidemic keratoconjunctivitis due to adenovirus types 3, 7, 8, and 19. Am J Ophthalmol 1976; 82: 781\u20135.","DOI":"10.1016\/0002-9394(76)90017-9"},{"key":"10.3238\/arztebl.2011.0475_ref22","doi-asserted-by":"crossref","unstructured":"Trousdale MD, Goldschmidt PL, N\u00f3brega R: Activity of Ganciclovir against human Adenovirus Type-5 infection in cell culture and cotton rat eyes. Cornea 1994; 13: 435\u20139.","DOI":"10.1097\/00003226-199409000-00011"},{"key":"10.3238\/arztebl.2011.0475_ref23","doi-asserted-by":"crossref","unstructured":"Hillenkamp J, Reinhard T, Ross RS, et al.: The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology 2002; 109: 845\u201350.","DOI":"10.1016\/S0161-6420(02)00992-2"},{"key":"10.3238\/arztebl.2011.0475_ref24","unstructured":"Gordon YJ, Romanowski EG, Araullo-Cruz T: Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model. Invest Ophthalmol Vis Sci 1994; 35: 4135\u201343."},{"key":"10.3238\/arztebl.2011.0475_ref25","doi-asserted-by":"crossref","unstructured":"Gordon YJ, Naesens L, DeClercq E, Maudgal PC, Veckeneer M: Treatment of adenoviral conjunctivitis with topical cidofovir. Cornea 1996; 15: 546.","DOI":"10.1097\/00003226-199609000-00018"},{"key":"10.3238\/arztebl.2011.0475_ref26","doi-asserted-by":"crossref","unstructured":"Hillenkamp J, Reinhard T, Ross RS, et al.: Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. Arch Ophthalmol 2001; 119(10): 1487\u201391.","DOI":"10.1001\/archopht.119.10.1487"},{"key":"10.3238\/arztebl.2011.0475_ref27","unstructured":"Romano A, Ladizensky E, Guarari-Rotman D, Revel M: Clinical effect of human-fibroblast-derived (beta) interferon in treatment of adeno-virus epidemic keratoconjunctivitis and its complication. Metab Pediatr Syst Ophthalmol 1983; 7: 31\u20136."},{"key":"10.3238\/arztebl.2011.0475_ref28","doi-asserted-by":"crossref","unstructured":"Adams CP Jr, Cohen EJ, Albrecht J, Laibson PR: Interferon treatment of adenoviral conjunctivitis. Am J Ophthalmol 1984; 98: 429\u201332.","DOI":"10.1016\/0002-9394(84)90125-9"},{"key":"10.3238\/arztebl.2011.0475_ref29","doi-asserted-by":"crossref","unstructured":"Wilhelmus KR, Dunkel EC, Herson J: Topical human fibroblast interferon for acute adenoviral conjunctivitis. Graefes Arch Clin Exp Ophthalmol 1987; 225: 461\u20134.","DOI":"10.1007\/BF02334177"},{"key":"10.3238\/arztebl.2011.0475_ref30","doi-asserted-by":"crossref","unstructured":"Reilly S, Dhillon BJ, Nkanza KM, et al.: Adenovirus type 8 keratoconjunctivitis\u2014an outbreak and its treatment with topical human fibroblast interferon. J Hyg (Lond) 1986; 96: 557\u201375.","DOI":"10.1017\/S0022172400066365"},{"key":"10.3238\/arztebl.2011.0475_ref31","doi-asserted-by":"crossref","unstructured":"Rossa V, Sundmacher R: Local prevention with interferon of \u201eepidemic\u201c conjunctivitis caused by a currently unidentifiable virus. Klin Monbl Augenheilkd 1991; 199: 192\u20134.","DOI":"10.1055\/s-2008-1046070"},{"key":"10.3238\/arztebl.2011.0475_ref32","doi-asserted-by":"crossref","unstructured":"Monnerat N, Bossart W, Thiel MA: Povidone-iodine for treatment of adenoviral conjunctivitis: an in vitro study. Klin Monbl Augenheilkd 2006; 223: 349\u201352.","DOI":"10.1055\/s-2006-926633"},{"key":"10.3238\/arztebl.2011.0475_ref33","doi-asserted-by":"crossref","unstructured":"Clement C, Capriotti JA, Kumar M, et al.: Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-Iodine in a rabbit model of adenoviral keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2011; 52(1): 339\u201344.","DOI":"10.1167\/iovs.10-5944"},{"key":"10.3238\/arztebl.2011.0475_ref34","doi-asserted-by":"crossref","unstructured":"Pleyer U: Viral ocular infections: Topical treatment and prevention. In: Behrens-Baumann W, Kramer A (eds.) Developments in Ophthalmology: Antiseptic prophylaxis and therapy of ocular infections. Basel: Karger 2001; 281\u201396.","DOI":"10.1159\/000065907"},{"key":"10.3238\/arztebl.2011.0475_ref35","doi-asserted-by":"crossref","unstructured":"Kinchington PR, Romanowski EG, Jerold Gordon Y: Prospects for adenovirus antivirals. J Antimicrob Chemother 2005; 55: 424\u20139.","DOI":"10.1093\/jac\/dki057"},{"key":"10.3238\/arztebl.2011.0475_ref36","doi-asserted-by":"crossref","unstructured":"Nagl M, Larcher C, Gottardi W: Activity of N-chlorotaurine against herpes simplex- and adenoviruses. Antiviral Res 1998; 38: 25\u201330.","DOI":"10.1016\/S0166-3542(98)00005-9"},{"key":"10.3238\/arztebl.2011.0475_ref37","doi-asserted-by":"crossref","unstructured":"Teuchner B, Nagl M, Schidlbauer A, et al.: Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis\u2014a double-blind, randomized, phase-2 clinical trial. J Ocul Pharmacol Ther 2005; 21: 157\u201365.","DOI":"10.1089\/jop.2005.21.157"},{"key":"10.3238\/arztebl.2011.0475_ref38","doi-asserted-by":"crossref","unstructured":"Lund OE, Stefani FH: Corneal histology after epidemic keratoconjunctivitis. Arch Ophthalmol 1978; 96: 2085\u20138.","DOI":"10.1001\/archopht.1978.03910060465016"},{"key":"10.3238\/arztebl.2011.0475_ref39","unstructured":"G\u00fcnther R: Pathologisch-anatomischer Befund einer Hornhaut bei Keratitis epidemica. Klin Monatsbl 1937; 103."},{"key":"10.3238\/arztebl.2011.0475_ref40","doi-asserted-by":"crossref","unstructured":"Sundmacher R, Engelskirchen U: Recurrent and persistent nummuli after epidemic keratoconjunctivitis. Klin Monbl Augenheilkd 1991; 198: 550\u20134.","DOI":"10.1055\/s-2008-1046030"},{"key":"10.3238\/arztebl.2011.0475_ref41","doi-asserted-by":"crossref","unstructured":"Levinger E, Slomovic A, Sansanayudh W, Bahar I, Slomovic AR: Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis. Cornea 2010; 29: 638\u201340.","DOI":"10.1097\/ICO.0b013e3181c33034"},{"key":"10.3238\/arztebl.2011.0475_ref42","doi-asserted-by":"crossref","unstructured":"Quentin CD, Tondrow M, Vogel M: Phototherapeutic keratectomy (PTK) after epidemic keratoconjunctivitis. Ophthalmologe. 1999; 96: 92\u20136.","DOI":"10.1007\/s003470050381"},{"key":"10.3238\/arztebl.2011.0475_ref43","doi-asserted-by":"crossref","unstructured":"Forster W, Grewe S, Busse H: Clinical use of the excimer laser in treatment of surface corneal opacities\u2014therapeutic strategy and case reports. Klin Monbl Augenheilkd 1993; 202: 126\u20139.","DOI":"10.1055\/s-2008-1045570"},{"key":"10.3238\/arztebl.2011.0475_ref44","doi-asserted-by":"crossref","unstructured":"Jawetz E, Kimura S, Nicholas AN, Thygeson P, Hanna L: New type of APC virus from epidemic keratoconjunctivitis. Science 1955; 122: 1190\u20131.","DOI":"10.1126\/science.122.3181.1190-a"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2011.0475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T10:29:32Z","timestamp":1661077772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2011.0475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,8]]},"references-count":44,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2011.0475","relation":{"is-cited-by":[{"id-type":"doi","id":"10.1007\/978-3-319-60980-5_6","asserted-by":"object"},{"id-type":"doi","id":"10.1007\/978-3-319-42840-6_1","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,8]]}}}